23.11.2011: Critical market access trial in COPD awarded to Metronomia

Today a multinational pharmaceutical customer awarded a critical  market access trial in COPD to Metronomia. Timelines for this trial are tight and critical as the study results shall build the major component in the AMNOG dossier to be delivered in 2013.

Due to the importance of the trial the sponsor decided to go with the established and well accepted eCRF solution clincase and Metronomia's e-clinical, data management and stats services.